Pharmafile - Manufacturing and Production News
The FDA has granted Orphan Drug Designation (ODD) for TLX66, for conditioning treatment prior to hematopoietic stem cell transplant (HSCT).
AstraZeneca has announced that Ondexxya has become the first approved medicine in Japan to reverse the anticoagulant effect of Factor Xa inhibitors...
UCB has revealed results from its Phase III/IIIb trials of BIMZELX (bimekizumab) for the treatment of adults with moderate to severe plaque psoriasis...
Those living in the US with CDKL5 deficiency disorder, or CDD, may now have access to the first FDA-approved treatment for their condition. ZTALMY® (...
In findings presented at the American Chemical Society’s (ACS) Spring Meeting for 2022, researchers reported on follow-up results form a Phase III...
Pfizer is voluntarily recalling certain hypertension medications due to the potential presence of impurities. The affected products have been...
Daiichi Sankyo and O’Brien’s Pharmacies Group have today announced the launch of a collaboration in North West England to offer a free Atrial...
Sanofi and Blackstone announced a strategic, risk-sharing €300 million collaboration, to advance innovative treatment for multiple myeloma.
Grifols has announced that XEMBIFY, its innovative 20% subcutaneous immunoglobulin (SCIG), has been approved by several European Union member state...
Illumia have announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumour genes and biomarkers,...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
